Comment on Pegylated Liposomal Doxorubicin Plus Docetaxel in Metastatic Breast Cancer

被引：3
|
作者：
Smith, Thomas J. [1 ]
Hillner, Bruce E.
机构：
[1] Virginia Commonwealth Univ, Massey Canc Ctr, Div Hematol Oncol, Richmond, VA 23284 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 08期
关键词：
COST-EFFECTIVENESS; TAXANE TREATMENT; PHASE-III; ANTHRACYCLINE; CAPECITABINE; COMBINATION; MONOTHERAPY; THERAPY;
D O I：
10.1200/JCO.2009.26.8243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E128 / E128
页数：1
相关论文
共 50 条
  • [1] Comment on Pegylated Liposomal Doxorubicin Plus Docetaxel in Metastatic Breast Cancer Reply
    Sparano, Joseph A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : E129 - E130
  • [2] Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer
    Minisini, Alessandro M.
    Andreetta, Claudia
    Fasola, Gianpiero
    Puglisi, Fabio
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 331 - 342
  • [3] Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study
    Collea, R. P.
    Kruter, F. W.
    Cantrell, J. E.
    George, T. K.
    Kruger, S.
    Favret, A. M.
    Lindquist, D. L.
    Melnyk, A. M.
    Pluenneke, R. E.
    Shao, S. H.
    Crockett, M. W.
    Asmar, L.
    O'Shaughnessy, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (10) : 2599 - 2605
  • [4] Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer
    Sparano, JA
    Malik, U
    Rajdev, L
    Sarta, C
    Hopkins, U
    Wolff, AC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3117 - 3125
  • [5] Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
    Schmid, Peter
    Krocker, J.
    Kreienberg, R.
    Klare, P.
    Kittel, K.
    Sommer, H.
    Heinrich, G.
    Steck, T.
    Lichtenegger, W.
    Elling, D.
    Kuemmel, S.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 401 - 406
  • [6] Non-pegylated liposomal doxorubicin and docetaxel as first-line treatment in metastatic breast cancer.
    Heilmann, V
    Eggemann, H
    Sommer, H
    Heinrich, G
    Blohmer, JU
    Mallmann, PK
    Krabisch, P
    Klare, P
    Schilling, J
    Kittel, K
    Elling, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 66S - 66S
  • [7] Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer
    Christodoulou, Christos
    Kostopoulos, Ioannis
    Kalofonos, Haralabos P.
    Lianos, Evangelos
    Bobos, Mattheos
    Briasoulis, Evangelos
    Gogas, Helen
    Razis, Evangelia
    Skarlos, Dimosthenis V.
    Fountzilas, George
    [J]. ONCOLOGY, 2009, 76 (04) : 275 - 285
  • [8] A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
    Huober, Jens
    Fett, Werner
    Nusch, Arnd
    Neise, Michael
    Schmidt, Marcus
    Wischnik, Arthur
    Gerhardt, Steffen
    Goehler, Thomas
    Lueck, Hans-Joachim
    Rost, Andreas
    [J]. BMC CANCER, 2010, 10
  • [9] Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
    Peter Schmid
    J. Krocker
    R. Kreienberg
    P. Klare
    K. Kittel
    H. Sommer
    G. Heinrich
    T. Steck
    W. Lichtenegger
    D. Elling
    S. Kümmel
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 64 : 401 - 406
  • [10] A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
    Jens Huober
    Werner Fett
    Arnd Nusch
    Michael Neise
    Marcus Schmidt
    Arthur Wischnik
    Steffen Gerhardt
    Thomas Goehler
    Hans-Joachim Lück
    Andreas Rost
    [J]. BMC Cancer, 10
12345